ORASURE TECHNOLOGIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ORASURE TECHNOLOGIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	128	167	182	155	172	234	387	405	186	115
Cost of revenue	40.2	68.1	68.1	60	69.9	116	239	234	106	66.8
Gross profit	88	99	114	94.6	102	118	148	172	79.4	48.2
Research and development	9.75	13.4	16.3	19.6	31	34.2	36.2	33.7	26	42.5
Selling and marketing	29.7	28.5	30.6	31.9	34.5	44.8	49.2	36.3	31	26.1
General and administrative	28.4	29.3	38.3	35.3	42.7	50.3	68.2	58.2	46.2	47.7
Operating expenses	67.8	58.7	85.2	76	107	128	171	139	108	120
Operating income	20.3	40.2	28.4	18.6	-5.18	-10.2	-22.2	32.7	-28.3	-72
Interest income							1.57	5.86	11.5	8.08
Other non-operating income	0.06	0.79	3.29	2.72	1.65	0.87	3.45	17.8	-0.38	0.23
Pre-tax income	20.3	41	31.7	21.3	-3.52	-9.29	-15.7	56.3	-16	-64.6
Income tax	0.6	10.1	11.3	4.68	11.4	13.7	1.46	2.6	1.8	1.8
Net income	19.7	30.9	20.4	16.7	-14.9	-23	-17.1	53.7	-19.5	-68.7
EBITDA	26	46.3	34.9	26	4.21	1.49	-6.85	53.6	-17.4	-61.8
EPS, basic	0.35	0.52	0.33	0.27	0.22	-0.32	-0.24	0.73	-0.26	-0.94
EPS, diluted	0.35	0.51	0.33	0.27	0.22	-0.32	-0.24	0.72	-0.26	-0.94
Shares, basic (weighted)	55.6	59.1	61.1	61.7	67.5	72	72.5	73.3	74.4	73.5
Shares, diluted (weighted)	56.5	61	62.5	62.2	67.5	72	72.5	74.4	74.4	73.5

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	108	71	88.4	75.7	161	117	84	290	268	199
Short-term investments	11.2	83	68.1	80.6	48.6	36.3	26.9	0
Receivables	19.8	42.5	34.8	36.9	38.8	45.3	70.8	40.2	23.8	22.2
Inventory	11.8	19.3	22.9	23.2	31.9	53.1	95.7	47.6	34.2	31.1
Other current assets	2.14	2.49	3.09	5.68	4.93	39.9	41.6	2.23	3.49	4.15
Total current assets	156	222	219	225	289	299	325	386	333	262
Property, plant and equipment	20	21.4	24.3	30.3	51.9	73.4	59.4	45.4	45.1	39.2
Lease right-of-use assets				5	4.46	9.06	10.4	12.3	13.4	12
Goodwill	18.8	20.1	18.5	36.2	40.4	40.3	35.1	35.7	40.3	43.4
Intangible assets	10.3	8.22	5.14	14.7	17.9	14.3	11.7	1.21	17.4	19
Long-term investments		20.7	44.8	33.4	47.7	17	0
Other non-current assets	2.33	3.93	3.55	3.16	1.97	5.07	1.09	1.22	1.53	1.3
Total assets	208	296	316	349	454	461	444	483	480	403
Accounts payable	4.63	10.2	10.6	9.57	17.4	28	38	13.2	8.17	6.52
Accrued liabilities	11.3	20.7	13.9	14.3	22.2	33.8	14.1	14.7	11.1	5.26
Deferred revenue	1.39	1.31	3.52	3.71	4.81	2.94	1.5	1.56	2.96	1.52
Total current liabilities	17.3	32.2	28	32.7	46.5	68.1	69.1	39.5	33.5	39.8
Lease liabilities				4.21	3.59	7.2	9.1	11.2	12.3	10.9
Other non-current liabilities	2.3	3.93	3.31	2.85	1.68	0.65	0.58	0.7	0.49	2.24
Total liabilities	22.1	38.1	32.2	42.2	55.9	80.5	79.8	52.2	69.3	62.3
Paid-in capital	351	388	401	402	505	511	520	530	538	531
Retained earnings	-150	-120	-99.2	-82.5	-97.5	-120	-138	-83.9	-103	-172
Other comprehensive income	-14.2	-10.3	-18.7	-12.1	-9.1	-10.1	-18.4	-14.9	-24.4	-18.4
Shareholders' equity	186	258	283	307	399	381	364	431	410	341
Total equity	186	258	283	307	399	381	364	431	410	341
Total liabilities and equity	208	296	316	349	454	461	444	483	480	403
Shares outstanding	56	60.7	61.3	61.7	71.7	72.1	72.7	73.5	74.6	70.4

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	19.7	30.9	20.4	16.7	-14.9	-23	-17.1	53.7	-19.5	-68.7
Depreciation and amortization	5.69	6.08	6.45	7.34	9.39	11.7	15.3	20.9	10.9	10.2
Stock-based compensation	6.06	6.97	15.2	4.06	7.14	7.81	11.6	10.7	11.9	10.1
Deferred income tax	-0.53	-0.65	-0.92	-1.46	-0.39	1.03	-1.65	0.1	-0.66	1.85
Change in receivables	-0.58	-22.1	6.69	-2.21	-2.32	-6.45	-25.2	31.1	15.9	1.95
Change in inventory	1.48	-7.39	-3.86	-1.04	-9.34	-21.2	-43.3	48.2	13.1	3.56
Change in payables	0.05	5.16	0.21	-1.54	7.38	3.23	2.63	-27	-7.58	-1.72
Cash from operations	24.6	28.2	39.1	9.8	5.81	-35.4	-47.2	142	27.4	-49
Capital expenditures	-4.35	-4.34	-6.34	-9.31	-26.7	-21.9	-6.77	-5.8	-3.8	-4.2
Acquisitions				-23.8	-3.04		0	0	-5.04	-3.61
Purchases of investments	-34.1			-92.2	-90.1	-25.8	-22.9	-74.7	-53.2	0
Sales and maturities of investments	30.4	69.3	153	93.5	108	67.9	47.4	102	53.1	0
Cash from investing	-8.07	-96.4	-17.4	-19.8	-14	-5.5	21.1	66.2	-39	-6.81
Debt repaid				-0.72
Stock issued	2.66	31.7	1.7	0.2	95	0.25	0.02	0.27	0.21	0
Share buybacks	-3.44	-1.24	-3.59	-3.71	-2.09	-2.11	-2.25	0	0	-15
Cash from financing	-1.16	30.4	-1.89	-4.68	92.5	-2.82	-3.83	-3.02	-4.18	-16.9
Exchange rate effect	0.32	0.84
Net change in cash	15.7	-36.9	15.6	-12.7	85.1	-44	-32.8	206	-22.6	-68.5
Free cash flow	20.2	23.8	32.7	0.49	-20.9	-57.3	-54	136	23.6	-53.2
Income taxes paid	1.12	4.31	17.1	10.6	9.26	13.7	9.4		1.8	1.84

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $3.93 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	42.6%	Gross profit / revenue.
Operating margin	-48.1%	Operating income / revenue.
EBITDA margin	-39.5%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-41.5%	Pre-tax income / revenue.
Net margin	-43.7%	Net income / revenue.
FCF margin	-42.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	-38.1%	Cash from operations / revenue.
Return on equity (ROE)	-15.5%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-13.6%	Net income / average total assets.
Return on invested capital (ROIC)	-27.1%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	39.7%	Research and development expense / revenue.
Stock-based pay / revenue	8.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	4.6%	Capital expenditures / revenue.
D&A / revenue	8.5%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-38.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-33.3%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	-7.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-39.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-31.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-13.9%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-279.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-325.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-16.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-2.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-3.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.9%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-2.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-1.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	0.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	1.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	8.88x	Current assets / current liabilities.
Quick ratio	7.41x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	6.39x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	11.9%	Total liabilities / total assets.
Working capital	$197.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	17.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	$256.2M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.31x	Revenue / average total assets.
Fixed asset turnover	2.91x	Revenue / average property, plant and equipment.
Inventory turnover	2.15x	Cost of revenue / average inventory.
Days inventory	170 days	365 x average inventory / cost of revenue.
Receivables turnover	4.39x	Revenue / average receivables.
Days sales outstanding	83 days	365 x average receivables / revenue.
Days payables	48 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	206 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.70	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$1.60	Revenue / diluted weighted shares.
FCF per share	-$0.69	Free cash flow / diluted weighted shares.
Operating cash flow per share	-$0.61	Cash from operations / diluted weighted shares.
Book value per share	$4.61	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$3.72	Tangible book value / shares outstanding.
Cash per share	$2.33	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$271.0M	Share price x shares outstanding.
Enterprise value	$110.5M	Market cap + total debt - cash - short-term investments.
P/S	2.41x	Market cap / revenue.
P/B	0.85x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.06x	Market cap / tangible book value, when positive.
EV/Sales	0.98x	Enterprise value / revenue.
FCF yield	-17.7%	Free cash flow / market cap.
Earnings yield	-18.1%	Net income / market cap (the inverse of P/E).
Shareholder yield	6.3%	(Dividends paid + share buybacks) / market cap.

What was ORASURE TECHNOLOGIES INC's revenue in fiscal 2025?

ORASURE TECHNOLOGIES INC reported revenue of $115.0M for fiscal 2025, 38.1% lower than the year before.

Was ORASURE TECHNOLOGIES INC profitable in fiscal 2025?

No. It reported a net loss of $68.7M.

How much free cash flow did ORASURE TECHNOLOGIES INC generate in fiscal 2025?

Cash from operations of $49.0M minus capital expenditures of $4.2M left free cash flow of -$53.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ORASURE TECHNOLOGIES INC